Gene · 189
Papers3,768
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,121 to 1,140 of 3,768
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Preparation of HeLa Total Membranes and Assay of Lipid-inhibition of Serine Palmitoyltransferase Activity. | Bio Protoc | 2020 | 33659326 | PubTator, text mining | PubMed |
| ORMDL2 Deficiency Potentiates the ORMDL3-Dependent Changes in Mast Cell Signaling. | Front Immunol | 2020 | 33643282 | PubTator, text mining | PubMed |
| Rotten to the Cortex: Ceramide-Mediated Lipotoxicity in Diabetic Kidney Disease. | Front Endocrinol (Lausanne) | 2020 | 33584550 | PubTator, text mining | PubMed |
| Blood-Brain Barrier Disruption and Hemorrhagic Transformation in Acute Ischemic Stroke: Systematic Review and Meta-Analysis. | Front Neurol | 2020 | 33551955 | PubTator, text mining | PubMed |
| PHGDH as a mechanism for resistance in metabolically-driven cancers. | Cancer Drug Resist | 2020 | 33511334 | PubTator, text mining | PubMed |
| Peroxisomal Metabolite and Cofactor Transport in Humans. | Front Cell Dev Biol | 2020 | 33505966 | PubTator, text mining | PubMed |
| Novel mutations in response to vitamin B6 in primary hyperoxaluria type 1 after only kidney transplantation: a case report. | Transl Androl Urol | 2020 | 33457257 | PubTator, text mining | PubMed |
| ORMDL3 and Asthma: Linking Sphingolipid Regulation to Altered T Cell Function. | Front Immunol | 2020 | 33424845 | PubTator, text mining | PubMed |
| Contribution of Dietary Oxalate and Oxalate Precursors to Urinary Oxalate Excretion. | Nutrients | 2020 | 33379176 | PubTator, text mining | PubMed |
| Knockdown of lactate dehydrogenase by adeno-associated virus-delivered CRISPR/Cas9 system alleviates primary hyperoxaluria type 1. | Clin Transl Med | 2020 | 33377632 | PubTator, text mining | PubMed |
| Dihydroceramides in Triglyceride-Enriched VLDL Are Associated with Nonalcoholic Fatty Liver Disease Severity in Type 2 Diabetes. | Cell Rep Med | 2020 | 33377125 | PubTator, text mining | PubMed |
| Current update and future directions on gut microbiome and nephrolithiasis. | Indian J Urol | 2020 | 33376261 | PubTator, text mining | PubMed |
| Effect of APOE ε4 on multimodal brain connectomic traits: a persistent homology study. | BMC Bioinformatics | 2020 | 33371873 | PubTator, text mining | PubMed |
| From Glucose to Lactate and Transiting Intermediates Through Mitochondria, Bypassing Pyruvate Kinase: Considerations for Cells Exhibiting Dimeric PKM2 or Otherwise Inhibited Kinase Activity. | Front Physiol | 2020 | 33335484 | PubTator, text mining | PubMed |
| Evaluating Sensory Integration/Sensory Processing Treatment: Issues and Analysis. | Front Integr Neurosci | 2020 | 33324180 | PubTator, text mining | PubMed |
| The Influence of Physical Activity on the Bioactive Lipids Metabolism in Obesity-Induced Muscle Insulin Resistance. | Biomolecules | 2020 | 33322719 | PubTator, text mining | PubMed |
| Development and validation of the peptic ulcer scale under the system of quality of life instruments for chronic diseases based on classical test theory and generalizability theory. | BMC Gastroenterol | 2020 | 33317456 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Hematological Malignancies: From Biomarkers to Therapeutic Tools. | Diagnostics (Basel) | 2020 | 33316884 | PubTator, text mining | PubMed |
| Transplantation for Primary Hyperoxaluria Type 1: Designing New Strategies in the Era of Promising Therapeutic Perspectives. | Kidney Int Rep | 2020 | 33305106 | PubTator, text mining | PubMed |
| Exploring the Possible Mechanism and Drug Targets of Huang-Qi-Gui-Zhi-Wu-Wu Decoction for the Treatment of Chemotherapy-Induced Peripheral Neuropathy on Network Pharmacology. | Evid Based Complement Alternat Med | 2020 | 33299447 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/189/papers?page=57